Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Andrew White, General Manager of Commercial Affairs at Rocket Pharmaceuticals, sold 3,080 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- Mark Andrew White, an officer at Rocket Pharmaceuticals, sold 3,080 shares of common stock on October 31, 2024.
- The sale was executed at a price of $16.625 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, White directly owns 69,140 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 10/31/2024 | Date of stock sale transaction. |
| 11/04/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.